Results 41 to 50 of about 5,255,854 (171)

Imaging Mass Cytometry Analysis of immune Checkpoint Inhibitor-Related Pneumonitis: A Case Report

open access: yesFrontiers in Immunology, 2022
Immune checkpoint inhibitor-related pneumonitis (CIP) is a rare but well-recognized immune-related adverse event (irAE), causes 35% of irAE related deaths.
Yuan Cheng   +8 more
doaj   +1 more source

Image_2_Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations.tif

open access: yes, 2023
IntroductionMonitoring of innate myeloid cells (IMC) is broadly applied in basic and translational research, as well as in diagnostic patient care.
Kassem, Sara   +25 more
core   +1 more source

Image_6_Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations.tif

open access: yes, 2023
IntroductionMonitoring of innate myeloid cells (IMC) is broadly applied in basic and translational research, as well as in diagnostic patient care.
Kassem, Sara   +25 more
core   +1 more source

Signal Amplification for Imaging Mass Cytometry

open access: yes, 2019
An enzyme-catalyzed reporter deposition stain has been developed for Imaging Mass Cytometry (IMC). The reagent consists of an alkaline phosphatase substrate tethered to a tellurophene which serves as reporter group for mass cytometry.
Jay Bassan (7339763)   +3 more
core   +1 more source

Metal Isotope-Tagged Nanomaterials for Mass Cytometry and Imaging: Advances and Biomedical Applications

open access: yesNano Biomedicine and Engineering
Mass cytometry (cytometry by time-of-flight (CyTOF)) and imaging mass cytometry (IMC) are transformative technologies that combine flow cytometry principles with time-of-flight mass spectrometry (TOF-MS).
Dongling Jia   +4 more
doaj   +1 more source

Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis

open access: yesBMC Cancer, 2020
Background Single rare cell characterization represents a new scientific front in personalized therapy. Imaging mass cytometry (IMC) may be able to address all these questions by combining the power of MS-CyTOF and microscopy.
Izhar S. Batth   +7 more
doaj   +1 more source

Supplementary Figure S4 from Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial

open access: yes, 2023
Supplementary Figure 4. Increased immune cell activity observed by imaging mass cytometry (IMC)
Peter Kuhn (15045998)   +17 more
core   +1 more source

Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry

open access: yesCell Reports, 2021
Summary: Type 2 diabetes mellitus (T2D) is a chronic age-related disorder characterized by hyperglycemia due to the failure of pancreatic beta cells to compensate for increased insulin demand.
Minghui Wu   +8 more
doaj   +1 more source

Predicting Oral Cancer From Precursor Lesions: The Case for a Standardized Framework of Analysis to Improve Prediction Modeling

open access: yesHead &Neck, EarlyView.
ABSTRACT Oral Cancer often occurs from the transformation of precursor lesions, and this offers an opportunity for early detection. Current methods to assess risk of precursor lesion progression to oral cancer incompletely predict risk. A multimodal framework that leverages machine learning is needed to improve prediction.
Michael E. Troka, James C. Gates
wiley   +1 more source

Supplementary Figure S2 from A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

open access: yes, 2023
Supplementary Figure 2. Analysis scheme for imaging mass cytometry (IMC).
Maheshwari Ramineni (15055547)   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy